EBOS enters trading halt ahead of $200m placement
Make us a preferred source
Make us a preferred source on Google
The news: Medical product wholesaler and distributor EBOS has entered a trading halt ahead of a $200 million equity placement.
The numbers: EBOS shares were up 1.3% to $35.54 before the trading halt was requested.
The context: Dual-listed EBOS requested the halt to enable UBS, as its underwriter, to conduct the placement bookbuild and determine the allocation of shares.
Trading of EBOS shares will be halted until the earlier of the company announcing the completion of the placement and the start of trading on the NZX on Friday.
The source: ASX
